Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.65 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.65 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | THPO | P40225 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | BLM | P54132 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.65 |
| ▸ | CETP | P11597 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | UBE2N | P61088 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.49 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313926 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL932976 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| Hexane SCHEMBL17093132 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10563903 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL7063457 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL15013420 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL25243382 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL440182 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL325349 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL10571108 | 1.00 | LMNA (0.65) | LMNACYP2D6SPHK1GMNNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005329-A | Cleansing composition, preparation method thereof and cleansing product | 广州宏度精细化工有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-114455573-B | Ultra-low density solid material, preparation method and application thereof | 天津海特热管理科技有限公司 | 2023-07-07 | — | — | CN | claimed |
| US-20180279610-A1 | GLYCEROL ETHER-BASED ANTIMICROBIAL COMPOSITIONS | VIROX TECHNOLOGIES INC. (CA) | 2018-10-04 | — | — | US | claimed |
| EP-3204038-A1 | COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME | Rochal Industries, LLC (US) | 2017-08-16 | — | — | EP | claimed |
| WO-2016057789-A1 | COMPOSITIONS AND KITS FOR TREATING PRURITUS AND METHODS OF USING THE SAME | ROCHAL INDUSTRIES, LLC (US) | 2016-04-14 | — | — | WO | claimed |
| US-20110218250-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2011-09-08 | — | — | US | claimed |
| EP-1992327-A1 | Composition based on glycerol ether/polyol mixtures | Air Liquide Santé (International) (FR) | 2008-11-19 | — | — | EP | claimed |
| US-20080255015-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | AIR LIQUIDE SANTE (INTERNATIONAL) (FR) | 2008-10-16 | — | — | US | claimed |
| EP-0747047-B1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | ROCHE POSAY LAB PHARMA (FR) | 1998-07-15 | — | — | EP | claimed |
| EP-0747047-A1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | LA ROCHE POSAY Laboratoire Pharmaceutique (FR) | 1996-12-11 | — | — | EP | claimed |
| EP-0547727-B1 | Skin and hands composition containing disinfectants and antiseptics | SCHUELKE & MAYR GMBH (DE) | 1996-03-13 | — | — | EP | claimed |
| EP-0547727-A2 | Skin and hands composition containing disinfectants and antiseptics | SCHÀLKE & MAYR GMBH (DE) | 1993-06-23 | — | — | EP | claimed |
| CN-122005329-A | Cleansing composition, preparation method thereof and cleansing product | 广州宏度精细化工有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-3890693-B1 | PROCESS FOR RESHAPING KERATIN FIBERS | KAO GERMANY GMBH (DE) | 2025-04-16 | — | — | EP | disclosed |
| CN-119372208-A | MRNA (messenger ribonucleic acid) encoding FGF18 protein, mRNA-LNP (messenger ribonucleic acid-lnP) delivery system and application of mRNA-LNP delivery system in preparation of medicines for cartilage repair and/or osteoarthritis treatment | 上海交通大学医学院附属第九人民医院 | 2025-01-28 | — | — | CN | disclosed |
| EP-4376796-A1 | TRANSPARENT AQUEOUS PERFUME COMPOSITION | V. Mane Fils (FR) | 2024-06-05 | — | — | EP | disclosed |
| EP-0747047-A1 | Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent | LA ROCHE POSAY Laboratoire Pharmaceutique (FR) | 1996-12-11 | — | — | EP | disclosed |
| EP-0547727-B1 | Skin and hands composition containing disinfectants and antiseptics | SCHUELKE & MAYR GMBH (DE) | 1996-03-13 | — | — | EP | disclosed |
| EP-0547727-A2 | Skin and hands composition containing disinfectants and antiseptics | SCHÀLKE & MAYR GMBH (DE) | 1993-06-23 | — | — | EP | disclosed |
| CN-1072593-A | The surfactant and the using method that contain alkyl phosphorylcholine or alkyl glycerol Phosphorylcholine | HEMAGEN PFC (US) | 1993-06-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180279610-A1 | GLYCEROL ETHER-BASED ANTIMICROBIAL COMPOSITIONS | MGLL, DAGLB, DEGS1 | LMNA 1856/4885CYP2D6 2282/4885SPHK1 193/4885 |
| US-20110218250-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | MGLL, DAGLA, DAGLB | LMNA 2280/4885CYP2D6 1793/4885SPHK1 86/4885 |
| US-20080255015-A1 | COMPOSITION BASED ON GLYCEROL ETHER/POLYOL MIXTURES | MGLL, DAGLA, DAGLB | LMNA 2341/4885CYP2D6 1929/4885SPHK1 83/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.